Stock Events

Stock Events

Galectin Therapeutics (GALT) Q2 2023 Earnings

14AugConfirmed

Nov 22

Q4 2022

Q1 2023

Q2 2023

-0.21

-0.19

-0.16

-0.14

Details

Expected EPS

-0.21

Actual EPS

-0.15

Surprise EPS

0.06

Surprise Percent

+28.57%

Description

Galectin Therapeutics (GALT) has reported earnings of -0.15 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.